Current research suggests that adiponectin exerts its effect by binding to its receptors and regulating AKT/mTOR/PI3K and MAPK signaling pathways, which are associated with cell proliferation and energy modulation, thereby inhibiting the activity and growth of thyroid cancer (16). The gene discussed is ADIPOQ; the disease is thyroid gland carcinoma.